ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Alzheimer's psychosis: ACP-204 safety trial expands
Symptom relief ENROLLING_BY_INVITATIONThis study tests the long-term safety of a drug called ACP-204 for people with Alzheimer's disease who also have psychosis (hallucinations or delusions). It lasts 52 weeks and includes 752 adults aged 55 to 95 who already completed a previous study of the same drug. The main goal…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Breakfast or not? new study tests Food's impact on brain drug
Knowledge-focused OngoingThis early-stage trial is testing how eating food changes the way the body absorbs a new experimental drug called LY03020. The drug is being developed for schizophrenia and psychosis related to Alzheimer's disease. Sixteen healthy volunteers will take the drug once with food and …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC